Alan C. O’Connor

1.5k total citations
27 papers, 496 citations indexed

About

Alan C. O’Connor is a scholar working on Economics and Econometrics, Management of Technology and Innovation and Health. According to data from OpenAlex, Alan C. O’Connor has authored 27 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 4 papers in Management of Technology and Innovation and 3 papers in Health. Recurrent topics in Alan C. O’Connor's work include Innovation Policy and R&D (7 papers), Health and Medical Research Impacts (3 papers) and Vaccine Coverage and Hesitancy (3 papers). Alan C. O’Connor is often cited by papers focused on Innovation Policy and R&D (7 papers), Health and Medical Research Impacts (3 papers) and Vaccine Coverage and Hesitancy (3 papers). Alan C. O’Connor collaborates with scholars based in United States, Australia and Ireland. Alan C. O’Connor's co-authors include Christopher S. Hayter, Andrew J. Nelson, Michael P. Gallaher, Gregory Tassey, Albert N. Link, Ruth Chadwick, Ross J. Loomis, Séamus O’Reilly, Troy M. Scott and Eugene Moylan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Reviews Drug Discovery and Annals of the New York Academy of Sciences.

In The Last Decade

Alan C. O’Connor

23 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan C. O’Connor United States	10	175	108	100	81	68	27	496
Iván Garibay United States	10	71 0.4×	82 0.8×	82 0.8×	28 0.3×	76 1.1×	49	390
Jai Ganesh India	11	71 0.4×	72 0.7×	106 1.1×	155 1.9×	36 0.5×	34	526
Amy Yu United States	5	132 0.8×	52 0.5×	231 2.3×	132 1.6×	29 0.4×	8	637
Benjamin Chiao China	8	129 0.7×	47 0.4×	226 2.3×	159 2.0×	42 0.6×	11	531
Yoshiko Okubo France	12	80 0.5×	33 0.3×	111 1.1×	147 1.8×	17 0.3×	19	586
Oh-Jin Kwon South Korea	10	268 1.5×	22 0.2×	156 1.6×	143 1.8×	41 0.6×	24	532
Ed J. Rinia Netherlands	8	40 0.2×	34 0.3×	60 0.6×	68 0.8×	22 0.3×	8	502
Robert R. Braam Netherlands	9	50 0.3×	54 0.5×	52 0.5×	72 0.9×	163 2.4×	9	614
Ali Alper Yayla United States	12	55 0.3×	87 0.8×	29 0.3×	112 1.4×	15 0.2×	25	541
Renger E. de Bruin Netherlands	10	24 0.1×	48 0.4×	80 0.8×	74 0.9×	46 0.7×	12	715

Countries citing papers authored by Alan C. O’Connor

Since Specialization

Citations

This map shows the geographic impact of Alan C. O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan C. O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan C. O’Connor more than expected).

Fields of papers citing papers by Alan C. O’Connor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan C. O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan C. O’Connor. The network helps show where Alan C. O’Connor may publish in the future.

Co-authorship network of co-authors of Alan C. O’Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Alan C. O’Connor. A scholar is included among the top collaborators of Alan C. O’Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan C. O’Connor. Alan C. O’Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnson, John L., et al.. (2025). Paths towards commercialization: evidence from NIH proof of concept centers. The Journal of Technology Transfer. 50(6). 2509–2531.

Hayter, Christopher S., et al.. (2025). Launching lean: insights from early-stage entrepreneurship development programs for scientists. The Journal of Technology Transfer.

Link, Albert N., et al.. (2022). Knowledge-based information and the effectiveness of R&D in small firms. Small Business Economics. 60(3). 891–900. 7 indexed citations

Jordan, Gretchen, et al.. (2021). Case Studies of Successful Technology Transfer from Federal Laboratories. RePEc: Research Papers in Economics. 5(3-4). 247–429.

O’Connor, Alan C., et al.. (2021). Insights from the evaluations of the NIH Centers for Accelerated Innovation and Research Evaluation and Commercialization Hubs programs. SHILAP Revista de lepidopterología. 6(1). e7–e7. 4 indexed citations

O’Connor, Alan C., et al.. (2021). High-tech infrastructure and economic growth: The Materials Genome Initiative. Science and Public Policy. 48(5). 649–661. 9 indexed citations

Hayter, Christopher S., et al.. (2018). Conceptualizing Academic Entrepreneurship Ecosystems: A Review, Analysis and Extension of the Literature. SSRN Electronic Journal. 11 indexed citations

Antman, Elliott M., Mason W. Freeman, Tomas Ganz, et al.. (2017). NIH Centers for Accelerated Innovations Program: principles, practices, successes and challenges. Nature Reviews Drug Discovery. 16(10). 663–664. 3 indexed citations

Link, Albert N., Alan C. O’Connor, & Troy M. Scott. (2015). Battery Technology for Electric Vehicles. 9 indexed citations

10.

Link, Albert N., et al.. (2015). Battery Technology for Electric Vehicles: Public science and private innovation. 3 indexed citations

11.

Moellendorf, Darrel, et al.. (2013). The Handbook of Global Ethics. 57(10). 526–527. 5 indexed citations

12.

Chadwick, Ruth & Alan C. O’Connor. (2013). Epigenetics and Personalized Medicine: Prospects and Ethical Issues. Personalized Medicine. 10(5). 463–471. 26 indexed citations

13.

O’Connor, Alan C., Erin Kennedy, Ross J. Loomis, et al.. (2013). Prospective cost–benefit analysis of a two-dimensional barcode for vaccine production, clinical documentation, and public health reporting and tracking. Vaccine. 31(31). 3179–3186. 13 indexed citations

14.

Chadwick, Ruth, et al.. (2012). Cesagen response to Nuffield Council on bioethics consultation on novel neurotechnologies: intervening in the brain. Lancaster EPrints (Lancaster University). 8 indexed citations

15.

O’Connor, Alan C., et al.. (2010). Health plan use of immunization information systems for quality measurement.. PubMed. 16(3). 217–24. 9 indexed citations

16.

O’Connor, Alan C. & Ross J. Loomis. (2010). 2010 economic analysis of role-based access control. Final report. 132–132. 18 indexed citations

17.

O’Reilly, Séamus, et al.. (2009). Safety of trastuzumab (Herceptin®) during pregnancy: two case reports. Cases Journal. 2(1). 9329–9329. 19 indexed citations

18.

O’Connor, Alan C., et al.. (2008). PUBLIC–PRIVATE PARTNERSHIP TO DEVELOP TECHNOLOGY INFRASTRUCTURE: A CASE STUDY OF THE ECONOMIC RETURNS OF DNA DIAGNOSTICS. Economics of Innovation and New Technology. 17(7-8). 649–661. 1 indexed citations

19.

Gallaher, Michael P., et al.. (2002). Planning Report 02-1: The Economic Impact of Role-Based Access Control | NIST. 28 indexed citations

20.

Gallaher, Michael P., et al.. (2002). The Economic Impact of Role-Based Access Control. 145–145. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact